Reports

Drug name	NICE TAs	Comments
Methoxy polyethelene glycol-epoetin beta (Mircera)	TA323 - Erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy	NHSE commissioned renal dialysis. CCG commissioned for use in cancer - NICE TA323.
Methylphenidate M/R tablets	TA98 - Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents	Specialist initiation only, ESCA
Methylphenidate tablets	TA98 - Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents	ESCAs and additional advice in relation to age of patient and CCG
Methylphenidate tablets#Amber	TA98 - Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents	ESCAs and additional advice in relation to age of patient and CCG
Mexiletine 167mg hard capsules (Namuscla®)	TA748 - Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders
Midostaurin	TA523 - Midostaurin for untreated acute myeloid leukaemia TA738 - Midostaurin for treating advanced systemic mastocytosis	For hospital use only
Mifamurtide	TA235 - Mifamurtide for the treatment of osteosarcoma	For hospital use only
Mifamurtide injection	TA235 - Mifamurtide for the treatment of osteosarcoma	For hospital use only
Migalastat (Galafold)	HST4 - Migalastat for treating Fabry disease
Mirabegron	TA290 - Mirabegron for treating symptoms of overactive bladder

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
Next page
Last page

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Reports